Abstract:Nanozymes are nanoscale materials that display enzyme-like properties, which have been improved to eliminate the limitations of natural enzymes and further broaden the use of conventional artificial enzymes. In the last decade, the research and exploration of nanozymes have attracted considerable attention in the chemical and biological fields, especially in the fields of biomedicine and tumor therapy. To date, plenty of nanozymes have been developed with the single or multiple activities of natural enzymes, including peroxidase (POD), catalase (CAT), superoxide dismutase (SOD), glucose oxidase (GOx). Tumor-characteristic metabolites can be transformed into toxic substances under the catalysis of nanozymes to kill tumor cells. However, the therapeutic effects of nanozymes greatly depend on their catalytic activity, which displays a lot of differences in vitro and in vivo. Moreover, the complex tumor environment (low pH, high H2O2 and GSH concentration, hypoxia, etc.) plays an important role in affecting their catalytic activity. Besides, the uncontrollable catalysis of nanozymes may lead to the destruction of normal tissues. To solve these problems, researchers have exploited several imaging methods to monitor the reaction processes during catalysis, including optical imaging methods (fluorescence and chemiluminescence), photoacoustic imaging, and magnetic resonance imaging. In this review, we have summarized the development of tumor treatment using nanozymes in recent years, along with the current imaging tools to monitor the catalyzing activity of nanozymes. Representative examples have been elaborated on to show the current development of these imaging tools. We hope this review will provide some instructive perspectives on the development of nanozymes and promote the applications of imaging-guided tumor therapeutics.

Enzyme-Catalyzed Molecular MR Imaging of Tumors

Enzyme-activated Nanomaterials for MR Imaging and Tumor Therapy

Molecular Imaging of Enzyme Activity in Vivo Using Activatable Probes

Most Recent Advances on Enzyme‐activatable Optical Probes for Bioimaging

Molecular Magnetic Resonance Imaging of Tumors with a PTPµ Targeted Contrast Agent.

Molecular Magnetic Resonance Imaging of Tumor Response to Therapy

Recent Advances in the Enzyme-Activatable Organic Fluorescent Probes for Tumor Imaging and Therapy

Recent progress in the imaging detection of enzyme activities in vivo

Recent progresses in small-molecule enzymatic fluorescent probes for cancer imaging

Gadolinium-based contrast agents for tumor targeting imaging

Magnetic Resonance Molecular Imaging in Cancer Research

The rational design of nanozymes for imaging-monitored cancer therapy

Nanoparticle-Based Activatable MRI Probes for Disease Imaging and Monitoring

Molecular Imaging Of Proteases In Cancer

Molecular Imaging of Proteases in Cancer.

Engineering a Dual-Receptor Targeted Multivalent Probe for Enhanced Magnetic Resonance Imaging of Metastatic Cancer

Emerging Strategies of Activatable MR Imaging Probes and Their Advantages for Biomedical Applications

An NIR Fluorescence Turn-on and MRl Bimodal Probe for Concurrent Real-time in vivo Sensing and Labeling of β-Galactosidase

Activatable NIR Fluorescence/MRI Bimodal Probes for in Vivo Imaging by Enzyme-Mediated Fluorogenic Reaction and Self-Assembly.

Structural and Molecular Fusion MRI Nanoprobe for Differential Diagnosis of Malignant Tumors and Follow-Up Chemodynamic Therapy.

A TME-activated <i>in situ</i> nanogenerator for magnetic resonance/fluorescence/photoacoustic imaging